NTR

Nutrien Stock in Brief

Today we're going to take a closer look at large-cap Industrials company Nutrien, whose shares are currently trading at $55.18. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

Nutrien Has Attractive P/B and P/E Ratios:

Nutrien Ltd. provides crop inputs and services. The company operates through Retail, Potash, Nitrogen, and Phosphate segments. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 22.19 and an average price to book (P/B) ratio of 4.06. In contrast, Nutrien has a trailing 12 month P/E ratio of 12.5 and a P/B ratio of 1.09.

When we divide Nutrien's P/E ratio by its expected EPS growth rate of the next five years, we obtain its PEG ratio of -0.52. Since it's negative, the company has negative growth expectations, and most investors will probably avoid the stock unless it has an exceptionally low P/E and P/B ratio.

The Company May Be Profitable, but Its Balance Sheet Is Highly Leveraged:

2018 2019 2020 2021 2022 2023
Revenue (MM) $19,636 $20,084 $20,908 $27,712 $37,884 $37,884
Revenue Growth n/a 2.28% 4.1% 32.54% 36.71% 0.0%
Operating Margins 2% 9% 4% 17% 28% 28%
Net Margins 18% 5% 3% 12% 20% 20%
Net Income (MM) $3,573 $1,028 $653 $3,257 $7,687 $7,687
Free Cash Flow (MM) $2,052 $3,665 $3,323 $3,886 $8,110 $8,110
Current Ratio 1.4 1.17 1.35 1.11 1.14 1.14
Total Debt (MM) $14,329 $16,480 $16,692 $16,183 $17,397 $17,397
Net Debt / EBITDA 5.99 4.32 5.27 2.33 1.29 1.29

Nutrien has growing revenues and no capital expenditures, decent operating margins with a positive growth rate, and irregular cash flows. However, the firm has a highly leveraged balance sheet. Finally, we note that Nutrien has positive expected EPS Growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS